1992
DOI: 10.1378/chest.102.4.1060
|View full text |Cite
|
Sign up to set email alerts
|

Pleural SC5b-9 in Differential Diagnosis of Tuberculous, Malignant, and Other Effusions

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
7
0
3

Year Published

1998
1998
2014
2014

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 16 publications
(10 citation statements)
references
References 9 publications
0
7
0
3
Order By: Relevance
“…The sensitivity was 84% for SC5b-9 and 81% for C3a-desArg. HARA et al [35] showed SC5b-9 had a higher sensitivity (100%) and ADA activity had a higher specificity than conventional tests (culture and/or histopathological examination). Discrimination of TB pleuritis from malignant effusions was better than discrimination from autoimmune or parapneumonic effusions.…”
Section: Cytokinesmentioning
confidence: 99%
“…The sensitivity was 84% for SC5b-9 and 81% for C3a-desArg. HARA et al [35] showed SC5b-9 had a higher sensitivity (100%) and ADA activity had a higher specificity than conventional tests (culture and/or histopathological examination). Discrimination of TB pleuritis from malignant effusions was better than discrimination from autoimmune or parapneumonic effusions.…”
Section: Cytokinesmentioning
confidence: 99%
“…Tuberculous pleural effusions are not always easy to diagnose because the standard criterion (the presence of a lymphocyte-rich exudate associated with case- ous necrotic granulomas in pleural biopsy tissue samples, positive Ziehl-Neelsen stains or Lowenstein cultures of effusion or tissue samples, and cutaneous sensitivity to purified tuberculin protein antigen derivative [PPD]) is not invariably satisfied. [6][7][8] In recent years, numerous authors studied possible biochemical markers such as adenosine deaminase (ADA), ADA isoenzymes, lysozyme, interferon gamma (IFN-␥), and other lymphokines [9][10][11][12][13][14][15][16][17][18] to improve diagnostic efficiency, but diagnosis is still sometimes difficult. In this article, we review all the case histories of patients with TPE who have been diagnosed with certainty in our center during the past 8 years.…”
Section: Arch Internmentioning
confidence: 99%
“…Research on SC5b-9, a product formed by the binding of S protein to C5b-9 complexes at the C5b-7 stage of assembly in consequence of complement activation, has found that this product is elevated in the pleural fluid of patients with tuberculous effusions unlike malignant and transudative effusions. 54,56 In particular Hara et al demonstrated that all tuberculous effusions in their study had SC5b-9 levels >2 mg/L, with malignant effusions <2 mg/L. 54 Using 2 mg/L as the cut-off they reported a sensitivity of 100% with a specificity of 79% (also raised in rheumatoid, parapneumonic and some treated malignant effusions) and found a positive correlation between pleural fluid ADA and SC5b-9.…”
Section: Complementmentioning
confidence: 93%
“…Increased serum complement activity is found in cancer and certain infections whilst decreased activity is seen in cirrhosis, glomerulonephritis, systemic lupus erythematosis (SLE), paroxysmal nocturnal haemoglobinuria (PNH), hereditary angioedema and malnutrition. 53 Despite the fact that several studies have highlighted complement activation in the pleural fluid of patients with rheumatoid arthritis, SLE and tuberculosis, 54,55 the routine analysis of complement (C3, C4) in rheumatoid arthritis and SLE is not recommended due to low specificity and the fact that serum rheumatoid factor (RF) and antinuclear antibody (ANA) are more sensitive and specific. 7 The measurement of complement activation products has also been analysed.…”
Section: Complementmentioning
confidence: 99%